Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer

Clinical Cancer Research

Volumn 7, Issue 5, 2001, Pages 1204-1213

  Shin, Dong M ^a   Perez Soler, Roman ^a   Zhang, Peter ^a   Lawhorn, Kristie ^a   Khuri, Fadlo R ^a   Glisson, Bonnie S ^a   Hong, Waun Ki ^a   Donato, Nicholas J ^b   Wu, Ji Y ^b   Shin, Hyung Ju C ^c   Myers, Jeffrey ^d   Clayman, Gary ^d   Mendelsohn, John ^e   Pfister, David ^f   Falcey, John ^g   Waksal, Harlan ^g  

^a Departments of Thoracic/Head and Neck Medical Oncology   (United States)

^b Departments of Bioimmunotherapy   (United States)

^c Departments of Pathology   (United States)

^d Departments of Head and Neck Surgery   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g ImClone Systems   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; MONOCLONAL ANTIBODY;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INFUSION; DRUG RECEPTOR BINDING; DRUG RESPONSE; FEMALE; FOLLICULITIS; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT CANCER; SKIN ALLERGY; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY COMPLEX; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PRECIPITIN TESTS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TREATMENT OUTCOME;

EID: 0034895886     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Signal transduction by receptors with tyrosine kinase activity
2. The EGF receptor: Structure, regulation, and potential role in malignancy
3. The epidermal growth factor receptor as a multifunctional allosteric protein
4. Receptors for epidermal growth factor and other polypeptide mitogens
5. Epidermal growth factor
6. Effect of epidermal growth factor on clonogenic growth of primary human tumor cells
7. Biological effect of epidermal growth factor on the in vitro growth of human tumors
8. Activation of the autocrine transforming growth factor αpathway in human squamous carcinoma cells
9. Autonomous growth of androgen-independent human prostatic carcinoma cells: Role of transforming growth factor α
10. Epidermal-growth-factor receptors in human bladder cancer: Comparison of invasive and superficial tumours
11. Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer
12. Epidermal growth factor receptors in non-small cell lung cancer
13. Epidermal growth factor regulates the in vitro sensitivity of human ovarian carcinoma cells to cisplatin
14. Enhancement of sensitivity of human squamous carcinoma cells to radiation by epidermal growth factor
15. Differences in, EGF-related radiosensitisation of human squamous carcinoma cells with high and low numbers of EGF receptors
16. Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors
17. Growth stimulation of A431 cells by epidermal growth factor: Identification of high-affinity receptors for epidermal growth factor by an antireceptor monoclonal antibody
18. Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies
19. Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model
20. Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes
21. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies
22. Autocrine regulation of membrane transforming growth factor-α cleavage
23. Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies
24. Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin
25. Reporting results of cancer treatment
26. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis
27. Tumor epidermal growth factor receptor studies in patients with nonsmall-cell lung cancer or head and neck cancer treated with monoclonal antibody RG 83852
28. Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity
29. Antibody-induced epidermal growth factor receptor dimerization mediates inhibition of autocrine proliferation of A431 squamous carcinoma cells
30. Epidermal growth factor receptor family and chemosensitization
31. Levels of TGF-α and EGFR protein in head and neck squamous cell carcinoma and patient survival
32. Chemotherapy and chemoprevention
33. Headneck cancer
34. Phase I and imaging trial of indium III-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma